down arrow

Strides Pharma

Part of MojoOne Strategy
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE939A01011
  • NSEID: STAR
  • BSEID: 532531
INR
607.45
24.75 (4.25%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 2.17 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

596.60636.65

52 Week

329.97804.62
Valuation
Technical
Day's Volume

CASH

2.17 lacs (-60.24%) Volume

Shareholding (Dec 2024)

FII

28.48%

Held by 236 FIIs

DII

16.93%

Held by 21 DIIs

Promoter

26.82%

iScoreScore
Part of MojoOne Strategy
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 6.00%

  • Poor long term growth as Net Sales has grown by an annual rate of 8.61% and Operating profit at 1.20% over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 6.85 times
2

54.25% of Promoter Shares are Pledged

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 5,598 Cr (Mid Cap)

stock-summary
P/E

21.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.43%

stock-summary
Debt Equity

0.91

stock-summary
Return on Equity

7.40%

stock-summary
Price to Book

2.36

Revenue and Profits (1 Year):
Net Sales:
1,154 Cr
(Quarterly Results - Dec 2024)
Net Profit:
88 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.43%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-19.0%
0%
-19.0%
1 Year
50.77%
0.58%
51.35%
2 Years
312.64%
2.28%
314.92%
3 Years
232.47%
3.13%
235.6%
4 Years
46.58%
1.70%
48.28%
5 Years
285.29%
4.25%
289.54%

Latest dividend: 2.5 per share ex-dividend date: Sep-09-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
8.61%
EBIT Growth (5y)
1.20%
EBIT to Interest (avg)
1.08
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.70
Tax Ratio
23.46%
Dividend Payout Ratio
-6.68%
Pledged Shares
54.25%
Institutional Holding
45.41%
ROCE (avg)
5.59%
ROE (avg)
2.78%
Valuation key factors
Factor
Value
P/E Ratio
21
Industry P/E
33
Price to Book Value
2.36
EV to EBIT
11.50
EV to EBITDA
8.83
EV to Capital Employed
1.72
EV to Sales
1.65
PEG Ratio
0.03
Dividend Yield
0.43%
ROCE (Latest)
13.32%
ROE (Latest)
7.40%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

FIIs

Pledged Promoter Holdings

54.2473

Mutual Funds

Held by 12 Schemes (10.86%)

FIIs

Held by 236 FIIs (28.48%)

Promoter with highest holding

Pronomz Ventures Llp (18.22%)

Highest Public shareholder

Quant Mutual Fund - Quant Business Cycle Fund (5.4%)

Individual Investors Holdings

20.86%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 14.71% vs 16.29% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 77.07% vs 162.06% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,153.67",
          "val2": "1,005.77",
          "chgp": "14.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "210.31",
          "val2": "141.98",
          "chgp": "48.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "52.18",
          "val2": "69.71",
          "chgp": "-25.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.43",
          "val2": "50.76",
          "chgp": "-104.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "87.95",
          "val2": "49.67",
          "chgp": "77.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.23%",
          "val2": "14.12%",
          "chgp": "4.11%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 18.62% vs 5.02% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 218.03% vs -22.46% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,288.62",
          "val2": "1,929.42",
          "chgp": "18.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "452.79",
          "val2": "319.72",
          "chgp": "41.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "162.54",
          "val2": "155.01",
          "chgp": "4.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-7.61",
          "val2": "-170.91",
          "chgp": "95.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "163.43",
          "val2": "-138.46",
          "chgp": "218.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.78%",
          "val2": "16.57%",
          "chgp": "3.21%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 17.28% vs 8.63% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 383.12% vs 54.02% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,442.29",
          "val2": "2,935.19",
          "chgp": "17.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "663.10",
          "val2": "461.70",
          "chgp": "43.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "214.72",
          "val2": "224.72",
          "chgp": "-4.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-10.04",
          "val2": "-120.15",
          "chgp": "91.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "251.38",
          "val2": "-88.79",
          "chgp": "383.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.26%",
          "val2": "15.73%",
          "chgp": "3.53%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 5.47% vs 20.13% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 65.15% vs 55.97% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,890.13",
          "val2": "3,688.39",
          "chgp": "5.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "582.38",
          "val2": "430.18",
          "chgp": "35.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "280.22",
          "val2": "261.14",
          "chgp": "7.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-139.46",
          "val2": "1.54",
          "chgp": "-9,155.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-70.62",
          "val2": "-202.64",
          "chgp": "65.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.97%",
          "val2": "11.66%",
          "chgp": "3.31%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,153.67
1,005.77
14.71%
Operating Profit (PBDIT) excl Other Income
210.31
141.98
48.13%
Interest
52.18
69.71
-25.15%
Exceptional Items
-2.43
50.76
-104.79%
Consolidate Net Profit
87.95
49.67
77.07%
Operating Profit Margin (Excl OI)
18.23%
14.12%
4.11%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 14.71% vs 16.29% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 77.07% vs 162.06% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
2,288.62
1,929.42
18.62%
Operating Profit (PBDIT) excl Other Income
452.79
319.72
41.62%
Interest
162.54
155.01
4.86%
Exceptional Items
-7.61
-170.91
95.55%
Consolidate Net Profit
163.43
-138.46
218.03%
Operating Profit Margin (Excl OI)
19.78%
16.57%
3.21%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 18.62% vs 5.02% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 218.03% vs -22.46% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
3,442.29
2,935.19
17.28%
Operating Profit (PBDIT) excl Other Income
663.10
461.70
43.62%
Interest
214.72
224.72
-4.45%
Exceptional Items
-10.04
-120.15
91.64%
Consolidate Net Profit
251.38
-88.79
383.12%
Operating Profit Margin (Excl OI)
19.26%
15.73%
3.53%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 17.28% vs 8.63% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 383.12% vs 54.02% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
3,890.13
3,688.39
5.47%
Operating Profit (PBDIT) excl Other Income
582.38
430.18
35.38%
Interest
280.22
261.14
7.31%
Exceptional Items
-139.46
1.54
-9,155.84%
Consolidate Net Profit
-70.62
-202.64
65.15%
Operating Profit Margin (Excl OI)
14.97%
11.66%
3.31%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 5.47% vs 20.13% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 65.15% vs 55.97% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Strides Pharma Science Ltd stock-summary
stock-summary
Strides Pharma Science Ltd
Mid Cap
Pharmaceuticals & Drugs
Strides Pharma Science Limited was originally incorporated under the name 'Strides Arcolab Limited ' on June 28, 1990. In FY 2016, Shasun Pharmaceuticals Limited merged with Strides Arcolab Limited forming a new identity 'Strides Shasun Limited', which became effective from 19 November, 2015 and name of the Company was changed to 'Strides Pharma Science Limited' from 'Strides Shasun Limited' effective on July 18, 2018.
Company Coordinates stock-summary
Company Details
No 201 Devavrata Sector 17, Vashi Navi Mumbai Maharashtra : 400703
stock-summary
Tel: 91-22-27892924/27893199
stock-summary
http://www.stridesarco.com
stock-summary
investors@stridesshasun.com
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."